Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Food firms test fry Pioneer's trans fat–free soybean oil

A Corrigendum to this article was published on 13 October 2010

This article has been updated

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 13 October 2010

    The version of the article originally published states that Monsanto petitioned the USDA for deregulation of two “soybean products with modified oil profiles, one with omega-3 fatty acids for nutrition and the other with enhanced texture and functionality, called high stearic acid soybeans.” The article should have stated that “Monsanto has petitioned for deregulation of Vistive Gold soybeans, with mono-unsaturated fat levels similar to that of olive oil, and saturated fat levels similar to canola oil, which would produce an oil more stable than regular soybean oil at high frying temperatures.” The high stearate soybeans are still in development. The error has been corrected in the HTML and PDF versions of the article.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waltz, E. Food firms test fry Pioneer's trans fat–free soybean oil. Nat Biotechnol 28, 769–770 (2010). https://doi.org/10.1038/nbt0810-769a

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0810-769a

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research